Table of Content

1 INTRODUCTION 25
1.1 STUDY OBJECTIVES 25
1.2 MARKET DEFINITION 26
1.2.1 INCLUSIONS AND EXCLUSIONS 26
1.3 MARKET SCOPE 27
1.3.1 MARKETS COVERED 27
1.3.2 YEARS CONSIDERED 28
1.4 CURRENCY CONSIDERED 28
TABLE 1 STANDARD CURRENCY CONVERSION RATES 28
1.5 LIMITATIONS 28
1.6 STAKEHOLDERS 29
1.7 SUMMARY OF CHANGES 29
1.8 RECESSION IMPACT 30
2 RESEARCH METHODOLOGY 31
2.1 RESEARCH DATA 31
FIGURE 1 RESEARCH DESIGN 31
2.1.1 SECONDARY DATA 32
2.1.1.1 Key data from secondary sources 33
2.1.2 PRIMARY DATA 33
FIGURE 2 PRIMARY SOURCES 33
2.1.2.1 Key data from primary sources 34
2.1.2.2 Key industry insights 35
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 35
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE PARTICIPANTS, BY COMPANY TYPE, DESIGNATION, AND REGION 36
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: DEMAND-SIDE PARTICIPANTS, BY END USER, DESIGNATION, AND REGION 36
2.2 MARKET SIZE ESTIMATION 37
FIGURE 6 VETERINARY VACCINES MARKET: SUPPLY-SIDE MARKET SIZE ESTIMATION 37
FIGURE 7 REVENUE SHARE ANALYSIS ILLUSTRATION: MERCK & CO., IN. 38
FIGURE 8 VETERINARY VACCINES MARKET: SUPPLY-SIDE ANALYSIS OF LEADING COMPANIES (2021) 39
FIGURE 9 VETERINARY VACCINES MARKET: CAGR PROJECTION FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2022–2027) 40
FIGURE 10 CAGR PROJECTION: SUPPLY-SIDE ANALYSIS 40
FIGURE 11 TOP-DOWN APPROACH 41
?
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 42
FIGURE 12 MARKET DATA TRIANGULATION METHODOLOGY 42
2.4 MARKET SHARE ANALYSIS 43
2.5 STUDY ASSUMPTIONS 43
2.6 RISK ASSESSMENT 43
TABLE 2 VETERINARY VACCINES MARKET: RISK ASSESSMENT ANALYSIS 43
2.7 LIMITATIONS 44
2.7.1 METHODOLOGY-RELATED LIMITATIONS 44
2.7.2 SCOPE-RELATED LIMITATIONS 44
2.8 VETERINARY VACCINES MARKET: RECESSION IMPACT 44
3 EXECUTIVE SUMMARY 45
FIGURE 13 VETERINARY VACCINES MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION) 45
FIGURE 14 VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2022 VS. 2027 (USD MILLION) 46
FIGURE 15 VETERINARY VACCINES MARKET, BY DISEASE, 2022 VS. 2027 (USD MILLION) 46
FIGURE 16 VETERINARY VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2022 VS. 2027 (USD MILLION) 47
FIGURE 17 VETERINARY VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2022 VS. 2027 (USD MILLION) 47
FIGURE 18 VETERINARY VACCINES MARKET: GEOGRAPHICAL SNAPSHOT 48
4 PREMIUM INSIGHTS 49
4.1 VETERINARY VACCINES MARKET OVERVIEW 49
FIGURE 19 RISING GROWTH IN COMPANION ANIMAL POPULATION TO DRIVE MARKET 49
4.2 ASIA PACIFIC: VETERINARY VACCINES MARKET, BY TECHNOLOGY (2021) 50
FIGURE 20 LIVE ATTENUATED VACCINES SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2021 50
4.3 VETERINARY VACCINES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 51
FIGURE 21 CHINA TO WITNESS HIGHEST CAGR DURING FORECAST PERIOD 51
4.4 VETERINARY VACCINES MARKET, BY REGION 52
FIGURE 22 ASIA PACIFIC REGION TO DOMINATE MARKET DURING FORECAST PERIOD 52
4.5 VETERINARY VACCINES MARKET: DEVELOPED VS. EMERGING ECONOMIES 52
FIGURE 23 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATE DURING FORECAST PERIOD 52
5 MARKET OVERVIEW 53
5.1 INTRODUCTION 53
5.2 MARKET DYNAMICS 53
FIGURE 24 VETERINARY VACCINES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 53
5.2.1 DRIVERS 54
5.2.1.1 Growth in companion animal population 54
TABLE 3 EUROPEAN PET POPULATION, BY ANIMAL, 2016–2022 (MILLION) 55
5.2.1.2 Rising incidence of zoonotic diseases 55
TABLE 4 ANIMAL DISEASE OUTBREAKS IN ASIA PACIFIC COUNTRIES (2009–2019) 56
5.2.1.3 Initiatives by various government agencies and animal associations 56
5.2.1.4 Rising demand for animal-derived food products 57
TABLE 5 PAST AND PROJECTED TRENDS IN CONSUMPTION OF MEAT AND MILK (DEVELOPED VS. EMERGING MARKETS) 57
TABLE 6 ASIA: COUNTRY-LEVEL CONSUMPTION OF ANIMAL-DERIVED FOOD PRODUCTS, 2020 VS. 2030 (THOUSAND METRIC TONS) 58
TABLE 7 ASIA: COUNTRY-LEVEL PRODUCTION OF ANIMAL-DERIVED FOOD PRODUCTS, 2020 VS. 2030 (THOUSAND METRIC TONS) 58
5.2.1.5 Growing demand for pet insurance and rising animal health expenditure 58
TABLE 8 US: AVERAGE PREMIUMS PAID (2019–2021) 59
FIGURE 25 CANADA: AVERAGE ANNUAL PREMIUMS, 2017–2021 59
FIGURE 26 US: PET INDUSTRY EXPENDITURE, 2010–2021 60
TABLE 9 US: BREAKDOWN OF PET INDUSTRY EXPENDITURE, 2020 VS. 2021 (USD BILLION) 60
TABLE 10 NORTH AMERICA: PET HEALTH INSURANCE MARKET, 2012–2021 (USD MILLION) 61
5.2.2 RESTRAINTS 61
5.2.2.1 High storage cost of vaccines 61
5.2.2.2 Rising pet care costs 61
FIGURE 27 US: BASIC ANNUAL EXPENSES FOR DOGS AND CATS, 2021 62
5.2.3 OPPORTUNITIES 62
5.2.3.1 Technological advancements 62
5.2.3.2 Untapped emerging markets 62
5.2.4 CHALLENGES 63
5.2.4.1 Inadequate surveillance and reporting systems 63
5.2.4.2 Lack of animal healthcare awareness in emerging countries 63
5.3 INDUSTRY TRENDS 64
5.3.1 GROWING SCALE OF VETERINARY BUSINESSES 64
5.4 REGULATORY ANALYSIS 64
5.4.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 64
TABLE 11 LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 64
5.4.2 US 67
5.4.3 EUROPE 67
5.4.4 REST OF THE WORLD 68
5.5 VALUE CHAIN ANALYSIS 69
FIGURE 28 VETERINARY VACCINES MARKET: VALUE CHAIN ANALYSIS 70
5.6 SUPPLY CHAIN ANALYSIS 70
FIGURE 29 VETERINARY VACCINES MARKET: SUPPLY CHAIN ANALYSIS 71
5.7 ECOSYSTEM ANALYSIS 72
FIGURE 30 VETERINARY VACCINES MARKET: ECOSYSTEM ANALYSIS 72
5.8 PORTER’S FIVE FORCES ANALYSIS 73
TABLE 12 PORTER’S FIVE FORCES ANALYSIS 73
5.8.1 THREAT OF NEW ENTRANTS 73
5.8.2 THREAT OF SUBSTITUTES 73
5.8.3 BARGAINING POWER OF SUPPLIERS 74
5.8.4 BARGAINING POWER OF BUYERS 74
5.8.5 INTENSITY OF COMPETITIVE RIVALRY 74
5.9 PATENT ANALYSIS 74
5.9.1 PATENT PUBLICATION TRENDS FOR VETERINARY VACCINES 74
FIGURE 31 PATENT PUBLICATION TRENDS (JANUARY 2013–MARCH 2023) 75
5.9.2 JURISDICTION AND TOP APPLICANT ANALYSIS 75
FIGURE 32 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTIONS) FOR VETERINARY VACCINES PATENTS (JANUARY 2013–MARCH 2023) 76
FIGURE 33 TOP APPLICANT COUNTRIES/REGIONS FOR VETERINARY VACCINES PATENTS (JANUARY 2013–MARCH 2023) 77
5.10 TECHNOLOGY ANALYSIS 77
5.11 INDICATIVE PRICING MODEL ANALYSIS 77
TABLE 13 AVERAGE SELLING PRICE OF VETERINARY VACCINES 77
5.11.1 AVERAGE SELLING PRICE TRENDS 78
5.12 KEY CONFERENCES AND EVENTS (2023–2025) 78
TABLE 14 VETERINARY VACCINES MARKET: DETAILED LIST OF CONFERENCES AND EVENTS 78
5.13 KEY STAKEHOLDERS AND BUYING CRITERIA 79
5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS 79
FIGURE 34 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR VETERINARY VACCINES 79
TABLE 15 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR VETERINARY VACCINES 79
5.13.2 BUYING CRITERIA 80
FIGURE 35 KEY BUYING CRITERIA FOR VETERINARY VACCINES 80
TABLE 16 KEY BUYING CRITERIA FOR VETERINARY VACCINES 80
6 VETERINARY VACCINES MARKET, BY TYPE 81
6.1 INTRODUCTION 82
TABLE 17 VETERINARY VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 82
6.2 LIVESTOCK VACCINES 82
TABLE 18 LIVESTOCK VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 83
TABLE 19 LIVESTOCK VACCINES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 83
6.2.1 BOVINE VACCINES 84
6.2.1.1 Bovine vaccines segment to dominate market 84
TABLE 20 BOVINE VACCINES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 84
6.2.2 SMALL RUMINANT VACCINES 85
6.2.2.1 Small ruminant vaccines segment to register lower growth in livestock vaccines market 85
TABLE 21 SMALL RUMINANT VACCINES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 85
6.3 PORCINE VACCINES 86
6.3.1 SECOND-LARGEST MARKET DURING FORECAST PERIOD 86
TABLE 22 PORCINE VACCINES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 86
6.4 POULTRY VACCINES 87
6.4.1 INCREASED PRODUCTION AND REARING OF POULTRY TO DRIVE MARKET GROWTH 87
TABLE 23 POULTRY VACCINES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 87
6.5 COMPANION ANIMAL VACCINES 87
TABLE 24 COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 88
TABLE 25 COMPANION ANIMAL VACCINES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 88
6.5.1 CANINE VACCINES 89
6.5.1.1 Canine vaccines segment to dominate companion animal vaccines market during forecast period 89
TABLE 26 CANINE VACCINES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 89
6.5.2 FELINE VACCINES 90
6.5.2.1 Rising prevalence of zoonotic diseases to drive demand for feline vaccines 90
TABLE 27 FELINE VACCINES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 90
6.6 AQUACULTURE VACCINES 91
6.6.1 VACCINATION PLAYS CRUCIAL ROLE IN COMMERCIAL FISH FARMING 91
TABLE 28 AQUACULTURE VACCINES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 91
6.7 OTHER ANIMAL VACCINES 92
TABLE 29 OTHER COMPANION ANIMAL VACCINES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 92
7 VETERINARY VACCINES MARKET, BY DISEASE 93
7.1 INTRODUCTION 94
TABLE 30 VETERINARY VACCINES MARKET, BY DISEASE, 2020–2027 (USD MILLION) 94
7.2 PORCINE DISEASES 94
7.2.1 PORCINE CIRCOVIRUS II TO ACCOUNT FOR LARGEST SHARE OF PORCINE VACCINES MARKET 94
TABLE 31 PORCINE VACCINES MARKET, BY DISEASE, 2020–2027 (USD MILLION) 95
TABLE 32 PORCINE DISEASES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 95
7.3 POULTRY DISEASES 96
7.3.1 INFECTIOUS BRONCHITIS SEGMENT TO ACCOUNT FOR LARGEST SHARE OF POULTRY VACCINES MARKET 96
TABLE 33 POULTRY VACCINES MARKET, BY DISEASE, 2020–2027 (USD MILLION) 96
TABLE 34 POULTRY DISEASES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 97
7.4 LIVESTOCK DISEASES 97
TABLE 35 LIVESTOCK VACCINES MARKET, BY DISEASE, 2020–2027 (USD MILLION) 97
TABLE 36 LIVESTOCK DISEASES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 98
7.4.1 BOVINE DISEASES 98
7.4.1.1 Foot-and-mouth disease segment to account for largest share of bovine vaccines market 98
TABLE 37 BOVINE VACCINES MARKET, BY DISEASE, 2020–2027 (USD MILLION) 99
TABLE 38 BOVINE DISEASES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 99
7.4.2 SMALL RUMINANT DISEASES 100
7.4.2.1 Clostridial disease segment to account for largest share of small ruminant vaccines market 100
TABLE 39 SMALL RUMINANT VACCINES MARKET, BY DISEASE, 2020–2027 (USD MILLION) 100
TABLE 40 SMALL RUMINANT DISEASES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 101
7.5 COMPANION ANIMAL DISEASES 101
TABLE 41 COMPANION ANIMAL VACCINES MARKET, BY DISEASE, 2020–2027 (USD MILLION) 101
TABLE 42 COMPANION ANIMAL DISEASES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 102
7.5.1 CANINE DISEASES 102
7.5.1.1 Canine rabies segment to account for largest share of canine vaccines market 102
TABLE 43 CANINE VACCINES MARKET, BY DISEASE, 2020–2027 (USD MILLION) 103
TABLE 44 CANINE DISEASES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 103
7.5.2 FELINE DISEASES 104
7.5.2.1 Feline viral rhinotracheitis segment to grow at highest CAGR during forecast period 104
TABLE 45 FELINE VACCINES MARKET, BY DISEASE, 2020–2027 (USD MILLION) 104
TABLE 46 FELINE DISEASES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 105
7.6 AQUACULTURE DISEASES 106
7.6.1 VACCINES IN AQUACULTURE MAJORLY DEVELOPED FOR SALMONIDS, CATFISH, AND SHRIMP 106
TABLE 47 AQUACULTURE DISEASES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 106
8 VETERINARY VACCINES MARKET, BY TECHNOLOGY 107
8.1 INTRODUCTION 108
TABLE 48 VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 108
8.2 LIVE ATTENUATED VACCINES 108
8.2.1 LIVE ATTENUATED VACCINES SEGMENT TO ACCOUNT FOR LARGEST MARKET SHARE DURING FORECAST PERIOD 108
TABLE 49 LIVE ATTENUATED VACCINES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 109
?
8.3 INACTIVATED VACCINES 110
8.3.1 RISING NEED TO DEVELOP ARTIFICIAL IMMUNITY AGAINST DISEASES FROM NON-LIVING PATHOGENS TO DRIVE GROWTH 110
TABLE 50 INACTIVATED VACCINES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 110
8.4 TOXOID VACCINES 111
8.4.1 TOXOID VACCINES USED WHEN BACTERIAL TOXINS CAUSE ILLNESS 111
TABLE 51 TOXOID VACCINES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 111
8.5 RECOMBINANT VACCINES 112
8.5.1 ADVANTAGES ASSOCIATED WITH RECOMBINANT VACCINES TO DRIVE DEMAND 112
TABLE 52 RECOMBINANT VACCINES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 112
8.6 OTHER VACCINES 113
TABLE 53 OTHER VACCINES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 113
9 VETERINARY VACCINES MARKET, BY ROUTE OF ADMINISTRATION 114
9.1 INTRODUCTION 115
TABLE 54 ROUTES OF ADMINISTRATION OF MAJOR VETERINARY VACCINES 115
TABLE 55 VETERINARY VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2020–2027 (USD MILLION) 117
9.2 INJECTABLE VACCINES 117
9.2.1 INJECTABLE VACCINES SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD 117
TABLE 56 INJECTABLE VETERINARY VACCINES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 118
9.3 ORAL VACCINES 118
9.3.1 ORAL VACCINES MAKE IMMUNIZATION EASIER 118
TABLE 57 ORAL VETERINARY VACCINES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 119
9.4 INTRANASAL/SPRAY VACCINES 120
9.4.1 LOW COST OF INTRANASAL/SPRAY VACCINES TO SUPPORT MARKET GROWTH 120
TABLE 58 INTRANASAL/SPRAY VETERINARY VACCINES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 120
10 VETERINARY VACCINES MARKET, BY DISTRIBUTION CHANNEL 121
10.1 INTRODUCTION 122
TABLE 59 VETERINARY VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 122
10.2 VETERINARY HOSPITALS 122
10.2.1 VETERINARY HOSPITALS FORM LARGEST AND FASTEST-GROWING END-USER SEGMENT IN VETERINARY VACCINES MARKET 122
TABLE 60 US: VETERINARY VISIT EXPENSES FOR CATS AND DOGS 123
TABLE 61 VETERINARY VACCINES MARKET FOR VETERINARY HOSPITALS, BY COUNTRY, 2020–2027 (USD MILLION) 123
?
10.3 VETERINARY CLINICS 124
10.3.1 INCREASING NUMBER OF PRIVATE CLINICAL PRACTICES TO SUPPORT MARKET GROWTH 124
TABLE 62 NUMBER OF PRIVATE CLINICAL PRACTICES, BY COUNTRY, 2019 VS. 2021 124
TABLE 63 VETERINARY VACCINES MARKET FOR VETERINARY CLINICS, BY COUNTRY, 2020–2027 (USD MILLION) 125
10.4 RETAIL PHARMACIES 125
10.4.1 EASY ACCESSIBILITY TO PHARMACEUTICALS TO SUPPORT MARKET GROWTH 125
TABLE 64 VETERINARY VACCINES MARKET FOR RETAIL PHARMACIES, BY COUNTRY, 2020–2027 (USD MILLION) 126
11 VETERINARY VACCINES MARKET, BY REGION 127
11.1 INTRODUCTION 128
TABLE 65 VETERINARY VACCINES MARKET, BY REGION, 2020–2027 (USD MILLION) 128
11.2 ASIA PACIFIC 128
11.2.1 ASIA PACIFIC: RECESSION IMPACT 129
FIGURE 36 ASIA PACIFIC: VETERINARY VACCINES MARKET SNAPSHOT 129
TABLE 66 ASIA PACIFIC: VETERINARY VACCINES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 130
TABLE 67 ASIA PACIFIC: VETERINARY VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 130
TABLE 68 ASIA PACIFIC: LIVESTOCK VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 130
TABLE 69 ASIA PACIFIC: COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 131
TABLE 70 ASIA PACIFIC: VETERINARY VACCINES MARKET, BY DISEASE, 2020–2027 (USD MILLION) 131
TABLE 71 ASIA PACIFIC: LIVESTOCK DISEASES MARKET, BY TYPE, 2020–2027 (USD MILLION) 131
TABLE 72 ASIA PACIFIC: COMPANION ANIMAL DISEASES MARKET, BY TYPE, 2020–2027 (USD MILLION) 132
TABLE 73 ASIA PACIFIC: VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 132
TABLE 74 ASIA PACIFIC: VETERINARY VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2020–2027 (USD MILLION) 132
TABLE 75 ASIA PACIFIC: VETERINARY VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 133
11.2.2 CHINA 133
11.2.2.1 China to dominate Asia Pacific veterinary vaccines market 133
TABLE 76 CHINA: VETERINARY VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 134
TABLE 77 CHINA: LIVESTOCK VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 134
TABLE 78 CHINA: COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 134
TABLE 79 CHINA: VETERINARY VACCINES MARKET, BY DISEASE, 2020–2027 (USD MILLION) 135
TABLE 80 CHINA: LIVESTOCK DISEASES MARKET, BY TYPE, 2020–2027 (USD MILLION) 135
TABLE 81 CHINA: COMPANION ANIMAL DISEASES MARKET, BY TYPE, 2020–2027 (USD MILLION) 135
TABLE 82 CHINA: VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 136
TABLE 83 CHINA: VETERINARY VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2020–2027 (USD MILLION) 136
TABLE 84 CHINA: VETERINARY VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 136
11.2.3 JAPAN 137
11.2.3.1 Increasing expenditure on pet healthcare to drive market growth 137
TABLE 85 PRODUCTION AND CONSUMPTION OF ANIMAL-DERIVED FOOD PRODUCTS IN JAPAN (2000 VS. 2030) (THOUSAND METRIC TONS) 137
TABLE 86 JAPAN: VETERINARY VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 138
TABLE 87 JAPAN: LIVESTOCK VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 138
TABLE 88 JAPAN: COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 138
TABLE 89 JAPAN: VETERINARY VACCINES MARKET, BY DISEASE, 2020–2027 (USD MILLION) 139
TABLE 90 JAPAN: LIVESTOCK DISEASES MARKET, BY TYPE, 2020–2027 (USD MILLION) 139
TABLE 91 JAPAN: COMPANION ANIMAL DISEASES MARKET, BY TYPE, 2020–2027 (USD MILLION) 139
TABLE 92 JAPAN: VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 140
TABLE 93 JAPAN: VETERINARY VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2020–2027 (USD MILLION) 140
TABLE 94 JAPAN: VETERINARY VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 140
11.2.4 INDIA 141
11.2.4.1 Dearth of veterinarians to restrain market growth 141
TABLE 95 PRODUCTION AND CONSUMPTION OF ANIMAL-DERIVED FOOD PRODUCTS IN INDIA (2000 VS. 2030) (THOUSAND METRIC TONS) 141
TABLE 96 INDIA: VETERINARY VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 142
TABLE 97 INDIA: LIVESTOCK VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 142
TABLE 98 INDIA: COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 142
TABLE 99 INDIA: VETERINARY VACCINES MARKET, BY DISEASE, 2020–2027 (USD MILLION) 143
TABLE 100 INDIA: LIVESTOCK DISEASES MARKET, BY TYPE, 2020–2027 (USD MILLION) 143
TABLE 101 INDIA: COMPANION ANIMAL DISEASES MARKET, BY TYPE, 2020–2027 (USD MILLION) 143
TABLE 102 INDIA: VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 144
TABLE 103 INDIA: VETERINARY VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2020–2027 (USD MILLION) 144
TABLE 104 INDIA: VETERINARY VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 144
?
11.2.5 AUSTRALIA 145
11.2.5.1 Increase in pet ownership to support market growth 145
TABLE 105 AUSTRALIA: VETERINARY VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 145
TABLE 106 AUSTRALIA: LIVESTOCK VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 145
TABLE 107 AUSTRALIA: COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 146
TABLE 108 AUSTRALIA: VETERINARY VACCINES MARKET, BY DISEASE, 2020–2027 (USD MILLION) 146
TABLE 109 AUSTRALIA: LIVESTOCK DISEASES MARKET, BY TYPE, 2020–2027 (USD MILLION) 146
TABLE 110 AUSTRALIA: COMPANION ANIMAL DISEASES MARKET, BY TYPE, 2020–2027 (USD MILLION) 147
TABLE 111 AUSTRALIA: VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 147
TABLE 112 AUSTRALIA: VETERINARY VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2020–2027 (USD MILLION) 147
TABLE 113 AUSTRALIA: VETERINARY VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 148
11.2.6 SOUTH KOREA 148
11.2.6.1 Growing companion animal population to drive market growth 148
TABLE 114 SOUTH KOREA: VETERINARY VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 148
TABLE 115 SOUTH KOREA: LIVESTOCK VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 149
TABLE 116 SOUTH KOREA: COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 149
TABLE 117 SOUTH KOREA: VETERINARY VACCINES MARKET, BY DISEASE, 2020–2027 (USD MILLION) 149
TABLE 118 SOUTH KOREA: LIVESTOCK DISEASES MARKET, BY TYPE, 2020–2027 (USD MILLION) 150
TABLE 119 SOUTH KOREA: COMPANION ANIMAL DISEASES MARKET, BY TYPE, 2020–2027 (USD MILLION) 150
TABLE 120 SOUTH KOREA: VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 150
TABLE 121 SOUTH KOREA: VETERINARY VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2020–2027 (USD MILLION) 151
TABLE 122 SOUTH KOREA: VETERINARY VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 151
11.2.7 THAILAND 151
11.2.7.1 Growth of pork and poultry industry to drive market 151
TABLE 123 THAILAND: VETERINARY VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 152
TABLE 124 THAILAND: LIVESTOCK VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 152
TABLE 125 THAILAND: COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 152
TABLE 126 THAILAND: VETERINARY VACCINES MARKET, BY DISEASE, 2020–2027 (USD MILLION) 153
TABLE 127 THAILAND: LIVESTOCK DISEASES MARKET, BY TYPE, 2020–2027 (USD MILLION) 153
TABLE 128 THAILAND: COMPANION ANIMAL DISEASES MARKET, BY TYPE, 2020–2027 (USD MILLION) 153
TABLE 129 THAILAND: VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 154
TABLE 130 THAILAND: VETERINARY VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2020–2027 (USD MILLION) 154
TABLE 131 THAILAND: VETERINARY VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 154
11.2.8 REST OF ASIA PACIFIC 155
TABLE 132 REST OF ASIA PACIFIC: VETERINARY VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 155
TABLE 133 REST OF ASIA PACIFIC: LIVESTOCK VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 155
TABLE 134 REST OF ASIA PACIFIC: COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 156
TABLE 135 REST OF ASIA PACIFIC: VETERINARY VACCINES MARKET, BY DISEASE, 2020–2027 (USD MILLION) 156
TABLE 136 REST OF ASIA PACIFIC: LIVESTOCK DISEASES MARKET, BY TYPE, 2020–2027 (USD MILLION) 156
TABLE 137 REST OF ASIA PACIFIC: COMPANION ANIMAL DISEASES MARKET, BY TYPE, 2020–2027 (USD MILLION) 157
TABLE 138 REST OF ASIA PACIFIC: VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 157
TABLE 139 REST OF ASIA PACIFIC: VETERINARY VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2020–2027 (USD MILLION) 157
TABLE 140 REST OF ASIA PACIFIC: VETERINARY VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 158
11.3 NORTH AMERICA 158
FIGURE 37 EXPECTED GROWTH IN NUMBER OF VETERINARIANS IN NORTH AMERICA 158
11.3.1 NORTH AMERICA: RECESSION IMPACT 159
FIGURE 38 NORTH AMERICA: VETERINARY VACCINES MARKET SNAPSHOT 159
TABLE 141 NORTH AMERICA: VETERINARY VACCINES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 160
TABLE 142 NORTH AMERICA: VETERINARY VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 160
TABLE 143 NORTH AMERICA: LIVESTOCK VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 160
TABLE 144 NORTH AMERICA: COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 161
TABLE 145 NORTH AMERICA: VETERINARY VACCINES MARKET, BY DISEASE, 2020–2027 (USD MILLION) 161
TABLE 146 NORTH AMERICA: LIVESTOCK DISEASES MARKET, BY TYPE, 2020–2027 (USD MILLION) 161
TABLE 147 NORTH AMERICA: COMPANION ANIMAL DISEASES MARKET, BY TYPE, 2020–2027 (USD MILLION) 162
TABLE 148 NORTH AMERICA: VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 162
TABLE 149 NORTH AMERICA: VETERINARY VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2020–2027 (USD MILLION) 162
TABLE 150 NORTH AMERICA: VETERINARY VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 163
11.3.2 US 163
11.3.2.1 US to dominate North American veterinary vaccines market 163
FIGURE 39 US: POPULATION OF DOGS, 2012–2020 (MILLION) 163
FIGURE 40 US: EXPENDITURE ON VET VISITS 164
TABLE 151 HEALTHCARE EXPENDITURE ON COMPANION ANIMALS, 2018 VS. 2020 164
FIGURE 41 INCOME OF VETERINARIANS IN US, 2017–2021 164
FIGURE 42 NUMBER OF VETERINARIANS IN US, 2016–2020 165
TABLE 152 US: NUMBER OF VETERINARIANS IN PRIVATE CLINICAL PRACTICES, 2014–2020 165
TABLE 153 US: VETERINARY VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 166
TABLE 154 US: LIVESTOCK VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 166
TABLE 155 US: COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 166
TABLE 156 US: VETERINARY VACCINES MARKET, BY DISEASE, 2020–2027 (USD MILLION) 167
TABLE 157 US: LIVESTOCK DISEASES MARKET, BY TYPE, 2020–2027 (USD MILLION) 167
TABLE 158 US: COMPANION ANIMAL DISEASES MARKET, BY TYPE, 2020–2027 (USD MILLION) 167
TABLE 159 US: VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 168
TABLE 160 US: VETERINARY VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2020–2027 (USD MILLION) 168
TABLE 161 US: VETERINARY VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 168
11.3.3 CANADA 169
11.3.3.1 Rising pet and livestock populations to support market growth 169
FIGURE 43 CANADA: COMPANION ANIMAL POPULATION, 2016–2020 (MILLION) 169
TABLE 162 CANADA: VETERINARY VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 170
TABLE 163 CANADA: LIVESTOCK VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 170
TABLE 164 CANADA: COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 170
TABLE 165 CANADA: VETERINARY VACCINES MARKET, BY DISEASE, 2020–2027 (USD MILLION) 171
TABLE 166 CANADA: LIVESTOCK DISEASES MARKET, BY TYPE, 2020–2027 (USD MILLION) 171
TABLE 167 CANADA: COMPANION ANIMAL DISEASES MARKET, BY TYPE, 2020–2027 (USD MILLION) 171
TABLE 168 CANADA: VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 172
TABLE 169 CANADA: VETERINARY VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2020–2027 (USD MILLION) 172
TABLE 170 CANADA: VETERINARY VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 172
11.4 EUROPE 173
11.4.1 EUROPE: RECESSION IMPACT 173
TABLE 171 EUROPE: VETERINARY VACCINES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 174
TABLE 172 EUROPE: VETERINARY VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 174
TABLE 173 EUROPE: LIVESTOCK VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 175
TABLE 174 EUROPE: COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 175
TABLE 175 EUROPE: VETERINARY VACCINES MARKET, BY DISEASE, 2020–2027 (USD MILLION) 175
TABLE 176 EUROPE: LIVESTOCK DISEASES MARKET, BY TYPE, 2020–2027 (USD MILLION) 176
TABLE 177 EUROPE: COMPANION ANIMAL DISEASES MARKET, BY TYPE, 2020–2027 (USD MILLION) 176
TABLE 178 EUROPE: VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 176
TABLE 179 EUROPE: VETERINARY VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2020–2027 (USD MILLION) 177
TABLE 180 EUROPE: VETERINARY VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 177
11.4.2 GERMANY 177
11.4.2.1 Germany to dominate European veterinary vaccines market 177
TABLE 181 GERMANY: VETERINARY VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 178
TABLE 182 GERMANY: LIVESTOCK VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 178
TABLE 183 GERMANY: COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 179
TABLE 184 GERMANY: VETERINARY VACCINES MARKET, BY DISEASE, 2020–2027 (USD MILLION) 179
TABLE 185 GERMANY: LIVESTOCK DISEASES MARKET, BY TYPE, 2020–2027 (USD MILLION) 179
TABLE 186 GERMANY: COMPANION ANIMAL DISEASES MARKET, BY TYPE, 2020–2027 (USD MILLION) 180
TABLE 187 GERMANY: VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 180
TABLE 188 GERMANY: VETERINARY VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2020–2027 (USD MILLION) 180
TABLE 189 GERMANY: VETERINARY VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 181
11.4.3 UK 181
11.4.3.1 Growing pet adoption to drive demand for veterinary vaccines 181
TABLE 190 UK: VETERINARY VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 182
TABLE 191 UK: LIVESTOCK VACCI



11.5 LATIN AMERICA 199
11.5.1 LATIN AMERICA: RECESSION IMPACT 199
TABLE 235 LATIN AMERICA: VETERINARY VACCINES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 199
TABLE 236 LATIN AMERICA: VETERINARY VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 200
TABLE 237 LATIN AMERICA: LIVESTOCK VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 200
TABLE 238 LATIN AMERICA: COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 200
TABLE 239 LATIN AMERICA: VETERINARY VACCINES MARKET, BY DISEASE, 2020–2027 (USD MILLION) 201
TABLE 240 LATIN AMERICA: LIVESTOCK DISEASES MARKET, BY TYPE, 2020–2027 (USD MILLION) 201
TABLE 241 LATIN AMERICA: COMPANION ANIMAL DISEASES MARKET, BY TYPE, 2020–2027 (USD MILLION) 201
TABLE 242 LATIN AMERICA: VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 202
TABLE 243 LATIN AMERICA: VETERINARY VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2020–2027 (USD MILLION) 202
TABLE 244 LATIN AMERICA: VETERINARY VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 202
11.5.2 BRAZIL 203
11.5.2.1 Well-established and rapidly growing livestock industry to promote growth 203
TABLE 245 BRAZIL: VETERINARY VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 203
TABLE 246 BRAZIL: LIVESTOCK VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 203
TABLE 247 BRAZIL: COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 204
TABLE 248 BRAZIL: VETERINARY VACCINES MARKET, BY DISEASE, 2020–2027 (USD MILLION) 204
TABLE 249 BRAZIL: LIVESTOCK DISEASES MARKET, BY TYPE, 2020–2027 (USD MILLION) 204
TABLE 250 BRAZIL: COMPANION ANIMAL DISEASES MARKET, BY TYPE, 2020–2027 (USD MILLION) 205
TABLE 251 BRAZIL: VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 205
TABLE 252 BRAZIL: VETERINARY VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2020–2027 (USD MILLION) 205
TABLE 253 BRAZIL: VETERINARY VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 206
11.5.3 MEXICO 206
11.5.3.1 Mexico to continue to be second-largest pet care market in Latin America during forecast period 206
TABLE 254 MEXICO: VETERINARY VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 206
TABLE 255 MEXICO: LIVESTOCK VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 207
TABLE 256 MEXICO: COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 207
TABLE 257 MEXICO: VETERINARY VACCINES MARKET, BY DISEASE, 2020–2027 (USD MILLION) 207
TABLE 258 MEXICO: LIVESTOCK DISEASES MARKET, BY TYPE, 2020–2027 (USD MILLION) 208
TABLE 259 MEXICO: COMPANION ANIMAL DISEASES MARKET, BY TYPE, 2020–2027 (USD MILLION) 208
TABLE 260 MEXICO: VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 208
TABLE 261 MEXICO: VETERINARY VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2020–2027 (USD MILLION) 209
TABLE 262 MEXICO: VETERINARY VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 209
11.5.4 REST OF LATIN AMERICA 209
TABLE 263 REST OF LATIN AMERICA: VETERINARY VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 210
TABLE 264 REST OF LATIN AMERICA: LIVESTOCK VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 210
TABLE 265 REST OF LATIN AMERICA: COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 210
TABLE 266 REST OF LATIN AMERICA: VETERINARY VACCINES MARKET, BY DISEASE, 2020–2027 (USD MILLION) 211
TABLE 267 REST OF LATIN AMERICA: LIVESTOCK DISEASES MARKET, BY TYPE, 2020–2027 (USD MILLION) 211
TABLE 268 REST OF LATIN AMERICA: COMPANION ANIMAL DISEASES MARKET, BY TYPE, 2020–2027 (USD MILLION) 211
TABLE 269 REST OF LATIN AMERICA: VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 212
TABLE 270 REST OF LATIN AMERICA: VETERINARY VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2020–2027 (USD MILLION) 212
TABLE 271 REST OF LATIN AMERICA: VETERINARY VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 212
11.6 MIDDLE EAST & AFRICA 213
11.6.1 LOW PORK PRODUCTION AND CONSUMPTION IN MIDDLE EASTERN COUNTRIES DUE TO RELIGIOUS CUSTOMS TO LIMIT GROWTH 213
TABLE 272 MIDDLE EAST & AFRICA: VETERINARY VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 214
TABLE 273 MIDDLE EAST & AFRICA: LIVESTOCK VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 214
TABLE 274 MIDDLE EAST & AFRICA: COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2020–2027 (USD MILLION) 214
TABLE 275 MIDDLE EAST & AFRICA: VETERINARY VACCINES MARKET, BY DISEASE, 2020–2027 (USD MILLION) 215
TABLE 276 MIDDLE EAST & AFRICA: LIVESTOCK DISEASES MARKET, BY TYPE, 2020–2027 (USD MILLION) 215
TABLE 277 MIDDLE EAST & AFRICA: COMPANION ANIMAL DISEASES MARKET, BY TYPE, 2020–2027 (USD MILLION) 215
TABLE 278 MIDDLE EAST & AFRICA: VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 216
TABLE 279 MIDDLE EAST & AFRICA: VETERINARY VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2020–2027 (USD MILLION) 216
TABLE 280 MIDDLE EAST & AFRICA: VETERINARY VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 216
12 COMPETITIVE LANDSCAPE 217
12.1 OVERVIEW 217
12.2 STRATEGIES ADOPTED BY KEY PLAYERS (JANUARY 2019 TO MARCH 2023) 218
FIGURE 44 KEY PLAYER STRATEGIES 218
12.3 REVENUE SHARE ANALYSIS OF TOP 5 PLAYERS 219
FIGURE 45 VETERINARY VACCINES MARKET: REVENUE SHARE ANALYSIS OF TOP PLAYERS (2017?2021) 219
12.4 MARKET SHARE ANALYSIS 219
FIGURE 46 VETERINARY VACCINES MARKET SHARE, BY KEY PLAYER (2021) 220
12.5 COMPANY FOOTPRINT 221
TABLE 281 VETERINARY VACCINES MARKET: BY TYPE 221
TABLE 282 VETERINARY VACCINES MARKET: BY DISEASE 222
TABLE 283 VETERINARY VACCINES MARKET: BY TECHNOLOGY 223
TABLE 284 VETERINARY VACCINES MARKET: BY ROUTE OF ADMINISTRATION 224
TABLE 285 VETERINARY VACCINES MARKET: BY DISTRIBUTION CHANNEL 225
12.6 COMPANY GEOGRAPHIC FOOTPRINT 226
TABLE 286 VETERINARY VACCINES MARKET: REGIONAL REVENUE MIX 226
12.7 COMPANY EVALUATION QUADRANT 227
12.7.1 STARS 227
12.7.2 EMERGING LEADERS 227
12.7.3 PERVASIVE PLAYERS 227
12.7.4 PARTICIPANTS 228
FIGURE 47 VETERINARY VACCINES MARKET: COMPANY EVALUATION QUADRANT (2021) 228
12.8 STARTUPS/SMES EVALUATION QUADRANT 229
12.8.1 PROGRESSIVE COMPANIES 229
12.8.2 DYNAMIC COMPANIES 229
12.8.3 STARTING BLOCKS 229
12.8.4 RESPONSIVE COMPANIES 229
FIGURE 48 VETERINARY VACCINES MARKET: EVALUATION QUADRANT FOR STARTUPS/SMES (2021) 230
12.9 COMPETITIVE BENCHMARKING 231
TABLE 287 VETERINARY VACCINES MARKET: DETAILED LIST OF KEY STARTUPS/SMES 231
12.10 COMPETITIVE SITUATION AND TRENDS 231
12.10.1 PRODUCT LAUNCHES & APPROVALS 231
TABLE 288 PRODUCT LAUNCHES & APPROVALS 231
12.10.2 DEALS 232
TABLE 289 DEALS 232
12.10.3 OTHER DEVELOPMENTS 233
TABLE 290 OTHER DEVELOPMENTS 233
?
13 COMPANY PROFILES 234
(Business overview, Products offered, Recent developments & MnM View)*
13.1 KEY PLAYERS 234
13.1.1 ZOETIS, INC. 234
TABLE 291 ZOETIS, INC.: BUSINESS OVERVIEW 234
FIGURE 49 ZOETIS, INC.: COMPANY SNAPSHOT (2022) 235
13.1.2 MERCK & CO., INC. 239
TABLE 292 MERCK & CO., INC.: BUSINESS OVERVIEW 239
FIGURE 50 MERCK & CO., INC.: COMPANY SNAPSHOT (2021) 240
13.1.3 BOEHRINGER INGELHEIM INTERNATIONAL GMBH 245
TABLE 293 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: BUSINESS OVERVIEW 245
FIGURE 51 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: COMPANY SNAPSHOT (2021) 246
13.1.4 ELANCO ANIMAL HEALTH 249
TABLE 294 ELANCO ANIMAL HEALTH: BUSINESS OVERVIEW 249
FIGURE 52 ELANCO ANIMAL HEALTH: COMPANY SNAPSHOT (2021) 250
13.1.5 VIRBAC 253
TABLE 295 VIRBAC: BUSINESS OVERVIEW 253
FIGURE 53 VIRBAC: COMPANY SNAPSHOT (2021) 254
13.1.6 CEVA SANT? ANIMALE 257
TABLE 296 CEVA SANT? ANIMALE: BUSINESS OVERVIEW 257
13.1.7 PHIBRO ANIMAL HEALTH CORPORATION 260
TABLE 297 PHIBRO ANIMAL HEALTH: BUSINESS OVERVIEW 260
FIGURE 54 PHIBRO ANIMAL HEALTH: COMPANY SNAPSHOT (2021) 260
13.1.8 HESTER BIOSCIENCES LIMITED 262
TABLE 298 HESTER BIOSCIENCES: BUSINESS OVERVIEW 262
FIGURE 55 HESTER BIOSCIENCES: COMPANY SNAPSHOT (2021) 263
13.1.9 NEOGEN CORPORATION 265
TABLE 299 NEOGEN CORPORATION: BUSINESS OVERVIEW 265
FIGURE 56 NEOGEN CORPORATION: COMPANY SNAPSHOT (2022) 266
13.1.10 HIPRA 267
TABLE 300 HIPRA: BUSINESS OVERVIEW 267
13.1.11 BIOG?NESIS BAG? 270
TABLE 301 BIOG?NESIS BAG?: BUSINESS OVERVIEW 270
13.1.12 TIANJIN RINGPU BIOTECHNOLOGY CO. LTD. 271
TABLE 302 TIANJIN RINGPU BIOTECHNOLOGY CO LTD: BUSINESS OVERVIEW 271
13.1.13 CHINA ANIMAL HUSBANDRY GROUP 273
TABLE 303 CHINA ANIMAL HUSBANDRY GROUP: BUSINESS OVERVIEW 273
13.1.14 JINYU BIO-TECHNOLOGY 274
TABLE 304 JINYU BIO-TECHNOLOGY: BUSINESS OVERVIEW 274
13.1.15 VAXXINOVA INTERNATIONAL BV 277
TABLE 305 VAXXINOVA INTERNATIONAL BV: BUSINESS OVERVIEW 277
*Details on Business overview, Products offered, Recent developments & MnM View might not be captured in case of unlisted companies.
13.2 OTHER COMPANIES 279
13.2.1 ENDOVAC ANIMAL HEALTH 279
13.2.2 BRILLIANT BIO PHARMA 279
13.2.3 APTIMMUNE 280
13.2.4 INDIAN IMMUNOLOGICALS LTD. 280
13.2.5 TORIGEN PHARMACEUTICALS, INC. 281
13.2.6 VEROVACCINES GMBH 281
13.2.7 INTAS PHARMACEUTICALS 282
13.2.8 OUROFINO ANIMAL HEALTH 282
13.2.9 BIOVAC 283
13.2.10 LABORATOIRE LCV 284
14 APPENDIX 285
14.1 DISCUSSION GUIDE 285
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 289
14.3 CUSTOMIZATION OPTIONS 291
14.4 RELATED REPORTS 291
14.5 AUTHOR DETAILS 292